Literature DB >> 24218037

Association between left ventricular dysfunction, anemia, and chronic renal failure. Analysis of the Heart Failure Prevalence and Predictors in Turkey (HAPPY) cohort.

A Kepez1, B Mutlu, M Degertekin, C Erol.   

Abstract

BACKGROUND: Anemia and chronic renal failure (CRF) are frequent comorbidities in patients with heart failure (HF), and they have been reported to be associated with increased mortality and hospitalization rates. HF, anemia, and CRF have been reported to interact with each other forming a vicious cycle termed cardio-renal-anemia syndrome. The aim of the present study was to evaluate the association of HF, anemia, and CRF using data from the large-scale"Heart Failure Prevalence and Predictors in Turkey (HAPPY)" study. PATIENTS AND METHODS: Among the HAPPY cohort, 3,369 subjects who had either left ventricular dysfunction (LVD) or normal left ventricular function on echocardiography or normal serum NT-proBNP levels were included in this analysis.
RESULTS: The prevalence of anemia and CRF was significantly higher in patients with LVD compared with subjects with normal ventricular function (20.7 % vs. 4.0 % and 19.0 % vs. 3.7 %, respectively; p < 0.001 for each). Binary logistic regression analyses for the presence of LVD, anemia, and CRF demonstrated that each one was an independent predictor for the presence of the others.
CONCLUSION: These findings point to the presence of cardio-renal-anemia syndrome and the necessity of treating these comorbidities in patients with HF.

Entities:  

Mesh:

Year:  2013        PMID: 24218037     DOI: 10.1007/s00059-013-3967-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  27 in total

Review 1.  Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.

Authors:  Yi-Da Tang; Stuart D Katz
Journal:  Circulation       Date:  2006-05-23       Impact factor: 29.690

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

Review 3.  Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease.

Authors:  Peter A McCullough; Norman E Lepor
Journal:  Rev Cardiovasc Med       Date:  2005       Impact factor: 2.930

4.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.

Authors:  Tamara B Horwich; Gregg C Fonarow; Michele A Hamilton; W Robb MacLellan; Jeff Borenstein
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

5.  Decreased hematopoiesis in bone marrow of mice with congestive heart failure.

Authors:  Per Ole Iversen; Per Reidar Woldbaek; Theis Tønnessen; Geir Christensen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-01       Impact factor: 3.619

6.  Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.

Authors:  Areef Ishani; Eric Weinhandl; Zihong Zhao; David T Gilbertson; Allan J Collins; Salim Yusuf; Charles A Herzog
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

7.  Hemodilution is common in patients with advanced heart failure.

Authors:  Ana-Silvia Androne; Stuart D Katz; Lars Lund; John LaManca; Alhakam Hudaihed; Katarzyna Hryniewicz; Donna M Mancini
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 8.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

9.  The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.

Authors:  Irene Betti; Gabriele Castelli; Alessandro Barchielli; Cinzia Beligni; Vittorio Boscherini; Leonardo De Luca; Gianni Messeri; Mihai Gheorghiade; Alan Maisel; Alfredo Zuppiroli
Journal:  J Card Fail       Date:  2009-01-21       Impact factor: 5.712

10.  [Heart failure prevalence and predictors in Turkey: HAPPY study].

Authors:  Muzaffer Değertekin; Cetin Erol; Oktay Ergene; Lale Tokgözoğlu; Mehmet Aksoy; Mustafa Kemal Erol; Mehmet Eren; Mahmut Sahin; Elif Eroğlu; Bülent Mutlu; Omer Kozan
Journal:  Turk Kardiyol Dern Ars       Date:  2012-06
View more
  1 in total

1.  Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey.

Authors:  Gülay Gök; Mehdi Zoghi; Ümit Yaşar Sinan; Salih Kılıç; Lale Tokgözoğlu
Journal:  Anatol J Cardiol       Date:  2019-03       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.